YD Bio (NASDAQ:YDES) Trading 7.9% Higher – Should You Buy?

YD Bio Limited (NASDAQ:YDES) shot up 7.9% during mid-day trading on Monday . The stock traded as high as $7.50 and last traded at $7.8770. 759 shares changed hands during mid-day trading, a decline of 98% from the average session volume of 37,850 shares. The stock had previously closed at $7.30.

Wall Street Analyst Weigh In

A number of research firms have issued reports on YDES. Weiss Ratings restated a “sell (d+)” rating on shares of YD Bio in a report on Monday, December 29th. Wall Street Zen raised shares of YD Bio from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, YD Bio has a consensus rating of “Sell”.

YD Bio Trading Up 5.7%

The company has a fifty day moving average of $10.26.

Institutional Trading of YD Bio

A hedge fund recently raised its stake in YD Bio stock. Geode Capital Management LLC grew its position in shares of YD Bio Limited (NASDAQ:YDES) by 10.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 58,363 shares of the biotechnology company’s stock after buying an additional 5,292 shares during the quarter. Geode Capital Management LLC owned 0.08% of YD Bio worth $711,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

About YD Bio

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.